Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema - Wikidata - awgldk - TriplyDB

Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema

Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema

http://www.wikidata.org/entity/Q36649134

about

Exogenous endophthalmitis in diabetic patients: a systemic review 25th RCOphth Congress, President's Session paper: 25 years of progress in vitreoretinal surgery Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings.Use of antivascular endothelial growth factor for diabetic macular edema.[Vitreoretinal surgery in Oman].Comparison of image-assisted versus traditional fundus examination.The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review.Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centres Surgical complications of primary rhegmatogenous retinal detachment: a meta-analysis.Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment.Comparison of standardized clinical classification with fundus photograph grading for the assessment of diabetic retinopathy and diabetic macular edema severity SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type.Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial.Comparative study of 27-gauge vs 25-gauge vitrectomy for epiretinal membrane.Endophthalmitis after intravitreal injections.Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy.Endophthalmitis in the era of small gauge transconjunctival sutureless vitrectomy--meta analysis and review of literature.Inflammation and pharmacological treatment in diabetic retinopathy.Current Perspectives of Prophylaxis and Management of Acute Infective Endophthalmitis.Outcomes of transconjunctival sutureless 27-gauge vitrectomy with silicone oil infusion.Review of Small Gauge Vitrectomy: Progress and Innovations Imaging of diabetic retinopathy and diabetic macular edema.A prospective and nationwide study investigating endophthalmitis following pars plana vitrectomy: clinical presentation, microbiology, management and outcome.A prospective and nationwide study investigating endophthalmitis following pars plana vitrectomy: incidence and risk factors.Ultrasound biomicroscopic findings of conventional and sutureless sclerotomy sites after 20-, 23-, and 25-G pars plana vitrectomy.In vivo comparison of 23- and 25-gauge sutureless vitrectomy incision architecture using spectral domain optical coherence tomography.Endophthalmitis after small-gauge vitrectomy: a retrospective case series from Sweden.Transconjunctival sutureless vitrectomy versus 20-gauge vitrectomy for vitreoretinal surgery: a meta-analysis of randomized controlled trials.Evaluation of conjunctival bleb detection after vitrectomy by ultrasound biomicroscopy, optical coherence tomography and direct visualization.Postoperative Endophthalmitis: A Review of Risk Factors, Prophylaxis, Incidence, Microbiology, Treatment, and Outcomes.Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease.Evaluation of mechanical closure resistance of sutureless vitrectomy sclerotomies after conjunctival cauterization with bipolar diathermy forceps.Assessment of Closure Competency of Sutureless Vitrectomy Sclerotomies After Scleral Hydration.Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy.Poly-N-isopropylacrylamide (pNIPAM): a reversible bioadhesive for sclerotomy closure.

P2860

Q26859314-E359026D-B766-4D0E-A81A-21ADDF75A62A Q27001938-22DB71CA-B0BD-49E9-BFBE-9FC852811307 Q33407131-CF79CC26-90D5-47E6-95AC-FD1726ADD693 Q33599732-4655CD57-F611-4BA0-907E-9CCDD7505FE7 Q33599770-7F5C86E8-B3C3-4B9B-8D47-E8FA33B4EC5C Q33688177-8206A054-5913-466A-914E-EFB484DEE911 Q34378757-3BE09656-9668-46F8-BCA3-5DC0E2A71B1F Q34603411-8A351A9D-DF65-46FB-BE22-1F87C5718469 Q35143721-7E66FEC9-6263-4756-9637-868E8617F405 Q36048840-C95B43A1-B905-431A-9FA0-CC26AF122629 Q36995938-64770694-45B2-4990-A248-9F50F4A63EB4 Q37186423-385CE687-A67B-4423-833B-93BF4593B16A Q37188529-DB4C8B38-F65C-45C1-9AA5-15516455F597 Q37412997-545BAE5B-B6AA-49A3-8071-F8C1B3323FB7 Q37544827-74B396F3-ADB8-4FFB-9884-D97E49865704 Q37789643-EFF36B49-C7D8-4DBF-AD8E-97540D41BFE4 Q37810937-CA18272C-43CD-43EB-8D7D-181EBFC4B629 Q38167309-EE7BA72F-7AFC-4E21-9858-310BB5908C34 Q38758366-02F2EC16-2AC5-4296-BE2B-AA1D44281A2C Q38812227-CB93376D-4CEF-48F2-87CF-523E7F95860C Q39355789-7CF74CAE-E29F-41D8-9674-95ED04A2F93C Q39984271-6DDFBF2B-D076-4E27-82AC-E41C242249B6 Q42221240-B8DEAAB3-2FB1-4DA7-8F39-B206599E8CA0 Q42233080-282D8982-0B9C-4CFA-9CF4-57E45D0C4732 Q43221721-83FAF5E0-1D25-41E2-9C01-4826B1425BFB Q43223873-E2391B19-313E-4028-8919-5708591970FE Q45108329-D1C836B4-9B6A-44C6-818B-64311BBBF4A7 Q45208482-C27FBEB8-E0AA-4DD3-831C-BC797A861D50 Q46572247-787F595C-381C-46B5-A8DD-59E4F84A81F2 Q49666628-2B8FCC0B-A374-4E7E-A147-BE39FC4744B5 Q50031588-CF970838-FE0C-4A3A-8F35-15CB2F6ACA9D Q50255225-3611B320-3BC1-4F89-9EC6-98B7FFE23852 Q50970664-1BB5A9E3-8FE2-42CC-A440-28A6109C06F3 Q51751386-9F1EFE48-9868-499E-9178-B1304CCC429D Q54368272-C5D2926D-9497-4B39-98CC-D85445A3EF16

P2860

Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema

http://www.wikidata.org/entity/Q36649134

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Agreement between clinician an ...... mab for diabetic macular edema

@ast

Agreement between clinician an ...... mab for diabetic macular edema

@en

type

label

Agreement between clinician an ...... mab for diabetic macular edema

@ast

Agreement between clinician an ...... mab for diabetic macular edema

@en

prefLabel

Agreement between clinician an ...... mab for diabetic macular edema

@ast

Agreement between clinician an ...... mab for diabetic macular edema

@en

P1433

Q36649134-5F8C242F-49C2-49EB-9937-CDA361566C01

P1476

Q36649134-42060FE1-AF76-4E6C-BF50-1D818E89614B

P2093

Q36649134-0431CEDA-B1C5-45F8-979B-37B8015CD2CD

Q36649134-12B24556-E1E0-4190-9B00-1403FABB385E

Q36649134-167408B7-D97E-4236-A9B9-CBC97A29D98B

Q36649134-4ED1B977-B337-4483-A163-4D9212C36C70

Q36649134-542254E1-7125-4BA0-BE95-DDAB63D85E12

Q36649134-6E5393B7-61FE-4D64-97EE-9149A1E9CD69

Q36649134-6E712724-F315-4494-927F-4741730D5FDC

Q36649134-7D4BBB90-84D6-4D3A-B0B2-667D486F5F3F

Q36649134-A6187E5E-E3F0-4F18-827B-A5F308BE775B

Q36649134-C555BD68-C437-4DE0-B8F7-712D1B9FF838

P2860

Q36649134-35611904-6867-47E1-A49A-321BC0A54949

Q36649134-434944DC-B78D-4E28-AD7B-F99542B3CAE7

Q36649134-D3D24A17-EEBE-45E8-9AC4-E85E75154937

Q36649134-DB0028F5-24D5-4588-9A5D-7B5AD3682247

Q36649134-E2D9C840-4AE9-4301-8C35-870D5D435AFC

P304

Q36649134-73964D04-59F8-46B8-9E3B-304B16E9C54F

P31

Q36649134-742C09E6-ABF1-4EEE-8846-2B8BC0757507

P356

Q36649134-D34931A3-1179-4F07-9828-A8CE51C5C2AF

P433

Q36649134-12B93EBD-CB42-48A8-87C2-5D4DC3313CA4

P478

Q36649134-C32E6902-0A5B-4E65-8390-27CF45D2C8E5

P577

Q36649134-E409EF7C-16A0-4FF6-AE65-7D53A4D864E3

P5875

Q36649134-234BD477-C02A-47D4-BD03-3CBEA1767992

P698

Q36649134-28ce4523-ef5c-4d78-99f2-80df88e051bf

Q36649134-A414B006-5E4B-4738-A1A6-8A7AA98BC554

P921

Q36649134-FCFE4B3B-0FA5-436E-9A2F-D130B9D1955E

P932

Q36649134-DE94B519-F60B-4DAE-8383-9FA4170DCF22

P356

IAE.0B013E31815E9313

P1433

P1476

Agreement between clinician an ...... mab for diabetic macular edema

@en

P2093

Clement K Chan

http://www.w3.org/2001/XMLSchema#string

Craig Kollman

http://www.w3.org/2001/XMLSchema#string

David J Browning

http://www.w3.org/2001/XMLSchema#string

Diabetic Retinopathy Clinical Research Network Study Group

http://www.w3.org/2001/XMLSchema#string

Haijing Qin

http://www.w3.org/2001/XMLSchema#string

Ingrid U Scott

http://www.w3.org/2001/XMLSchema#string

Matthew D Davis

http://www.w3.org/2001/XMLSchema#string

Neil M Bressler

http://www.w3.org/2001/XMLSchema#string

Ronald P Danis

http://www.w3.org/2001/XMLSchema#string

Susan B Bressler

http://www.w3.org/2001/XMLSchema#string

P2860

The Los Angeles Latino Eye Study: design, methods, and baseline data.

Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study.

Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review.

Screening for diabetic retinopathy--comparison of a nurse and a doctor with retinal photography.

Role of diabetologist in evaluating diabetic retinopathy.

P304

36-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/IAE.0B013E31815E9313

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5665866

http://www.w3.org/2001/XMLSchema#string

P698

18185135

http://www.w3.org/2001/XMLSchema#string

P921

P932

2377181

http://www.w3.org/2001/XMLSchema#string